Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Keratosis, Actinic 2Skin Neoplasms 1Precancerous Conditions 1Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Cyclosporine 4Antilymphocyte Serum 4Aminolevulinic Acid 4Whole-Body Irradiation 3Tacrolimus 3Mycophenolic Acid 3Methotrexate 3Etoposide 3Epoetin Alfa 3Darbepoetin alfa 3Busulfan 3Sirolimus 2Morphine 2Methylprednisolone 2Melphalan 2Filgrastim 2Biopsy 2tremelimumab 1tirbanibulin 1pyroxamide 1perillyl alcohol 1ferrous sulfate 1ferric gluconate 1arginine butyrate 1Triamcinolone 1Therapeutics 1Tetradecanoylphorbol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Deoxyribonuclease (Pyrimidine Dimer) × Dermatologic × Clear all
NCT00002811 2013-11-06

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

National Cancer Institute (NCI)

Phase 3 Unknown
30 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡